Adjuvance Technologies
PrivateLast Round
Series A
May 27, 2020
Total Funding Raised
$47.86M
Company Overview
Adjuvance Technologies is a biopharmaceutical company that develops and manufactures proprietary saponin-based vaccine adjuvants to improve immune responses.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Adjuvance Technologies Comparables
Compare Adjuvance Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Q-Vant Biosciences | 85% | |
| TollereBio | 82% | |
| Inimmune | 79% | |
Adjuvance Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 27, 2020 | ||||
| Grant | May 19, 2020 | ||||
| Series A | Jan 30, 2020 | ||||
| Grant | Sep 1, 2017 | ||||
| Seed | Nov 14, 2016 | ||||
Grant | Jun 6, 2014 |
Adjuvance Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
| NIH RADx | Grant |
| Morningside Ventures | Seed, Series A |
| Nebraska Department of Economic Development | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 19, 2020
$1.47M grant from National Institute of Allergy and Infectious Diseases
- Jun 6, 2014
$1.7M grant received from NIH RADx
Adjuvance Technologies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Adjuvance Technologies's valuation, stock price, and market status.